While the CHEK2 gene is widely recognized as a multi‐organ cancer susceptibility gene, the role of CHEK2I157T has been debated, but several case–control analyses have shown a correlation between this variant and the susceptibility for various types of cancer, like breast, colorectal, and prostate cancer [43]. This evidence concerns the gene CHEK2 and prostate carcinoma.